Zacks.com on MSN3h
AZN, Daiichi Withdraw EU Filing for Dato-DXd in Nonsquamous NSCLCAstraZeneca AZN and its Japanese partner Daiichi Sankyo announced that they have voluntarily withdrawn the marketing ...
Merck will encounter some Keytruda-related issues toward the end of the decade, but the company's business and pipeline are ...
This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...
The year 2024 saw the U.S. stock market make new records, with major indices breaching key milestones. While many stocks ...
The global market for barrett’s esophagus with dysplasia treatment is poised for significant growth, with a projected ...
Shares of Merck & Co. Inc. MRK inched 0.08% higher to $99.45 Tuesday, on what proved to be an all-around favorable trading ...
A Fremont pharmaceutical company received an investment of approximately $50 million in a private placement from Merck & Co.
A Fremont pharmaceutical company received an investment of approximately $50 million — about $3.56 per share — in a private ...
Treatment Market. According to a recent market analysis conducted by Future Market Insights, the global molluscum contagiosum ...
On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $98.05 which represents a decrease of $-1.47 or -1.48% from the prior close of $99.52. The stock opened at $98.83 and touched a ...
Merck, a leading global pharmaceutical company that produces a range of medicines, vaccines, and animal healthcare products, ...
Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback